BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) ("Profound” or the "Company”) today announced that it intends to offer and sell common shares (the "Common Shares”) in an underwritten public offering (the "Offering”). In addition, Profound expects to grant the underwriters of the Offering a 30-day option to purchase up to an additional 15% of the Common Shares sold in the Offering. All of the securities in the Offering are being offered by Profound. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering. The net proceeds of the Offering are expected to be used: (i) to fund the continued commercialization of the TULSA-PRO® system in the United States, (ii) to fund the continued development and commercialization of the TULSA-PRO® system and the Sonalleve® system globally, and (iii) for working capital and general corporate purposes. The Offering is expected to be completed pursuant to an underwriting agreement to be entered into between the Company and Raymond James Ltd. and Lake Street Capital Markets as co-lead underwriters and joint bookrunners, and a third underwriter. The Offering is expected to take place in each of the provinces and territories of Canada, except the province of Québec, and in the United States. The Offering is expected to close on or about December 10, 2024, subject to customary closing conditions including, but not limited to, the receipt of all necessary approvals including the approval of the Toronto Stock Exchange. Profound will notify the Nasdaq Capital Market in accordance with the rules of that exchange. In connection with the Offering, the Company has filed a preliminary prospectus supplement (the "Preliminary Prospectus Supplement”) and intends to file a subsequent prospectus supplement (the "Prospectus Supplement”) to its short form base shelf prospectus dated July 10, 2024 (the "Base Shelf Prospectus”) in each of the provinces and territories of Canada relating to the proposed Offering. The Prospectus Supplement will also be filed in the United States with the U.S. Securities and Exchange Commission (the "SEC”) as part of the Company's effective registration statement on Form F-10 (File no. 333-280236), as amended, previously filed under the multijurisdictional disclosure system adopted by the United States. Access to the Base Shelf Prospectus, the Prospectus Supplement, and any amendments to the documents will be provided in accordance with securities legislation relating to procedures for providing access to a shelf prospectus supplement, a base shelf prospectus and any amendment. The Base Shelf Prospectus is, and the Prospectus Supplement will be (within two business days of the date hereof), accessible on SEDAR+ at www.sedarplus.com and on EDGAR at www.sec.gov . The Common Shares are offered under the Prospectus Supplement. An electronic or paper copy of the Base Shelf Prospectus, the Prospectus Supplement (when filed), and any amendment to the documents may be obtained without charge, from Raymond James Ltd., Scotia Plaza, 40 King St. W., 54th Floor, Toronto, Ontario M5H 3Y2, Canada, or by telephone at 416-777-7000 or by email at [email protected] by providing the contact with an email address or address, as applicable. Copies of the Prospectus Supplement and the Base Shelf Prospectus will be available on EDGAR at www.sec.gov or may be obtained without charge from Raymond James & Associates, Inc., Attention: Equity Syndicate, 880 Carillon Parkway, St. Petersburg, Florida 33716, by telephone at (800) 248-8863, or by email at [email protected] , and from Lake Street Capital Markets, LLC, 920 2nd Ave S - Ste 700, Minneapolis, MN 55402, [email protected] , (612) 326-1305. The Base Shelf Prospectus and Prospectus Supplement contain important, detailed information about the Company and the proposed Offering. Prospective investors should read the Base Shelf Prospectus and Prospectus Supplement (when filed) before making an investment decision. No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, territory, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, territory, state or jurisdiction. About Profound Medical Corp. Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Forward-Looking Statements This release includes forward-looking statements regarding Profound and its business which may include, but is not limited to, the Offering, including the Offering's timing, pricing, underwriters, size, terms, selling jurisdictions, closing, over-allotment option, and use of proceeds; the availability and timing of the final prospectus supplement; and, the expectations regarding the efficacy and commercialization of Profound's technology. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of Profound. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, regulatory approvals, reimbursement, economic factors, the equity markets generally and risks associated with growth and competition. Although Profound has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Additional information about the risks and uncertainties of forward-looking statements and the assumptions upon which they are based is contained in the Company's filings with securities regulators, which are available electronically through SEDAR+ at www.sedarplus.com and EDGAR at www.sec.gov . Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Profound undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, other than as required by law. For further information, please contact: Stephen Kilmer Investor Relations [email protected] T: 647.872.4849US senator says mysterious drones spotted in New Jersey should be 'shot down, if necessary'
Republican delegates decide Saturday who will lead the state party
US senator says mysterious drones spotted in New Jersey should be 'shot down, if necessary'
NoneDENVER (AP) — Travis Hunter made a pair of proclamations Thursday: He’s for sure entering the NFL draft after this season, but not until he sees Colorado all the way through the College Football Playoff — if the Buffaloes make it there. The first was already a given for the draft-eligible junior who plays both receiver and cornerback. The second is a risk-reward play for a projected high first-round pick who averages around 120 snaps a game. In years past, it took two extra postseason wins to capture a national title. Now, it could take up to four additional contests. That’s more of a chance to shine, but also more chance for an injury. “I don’t think nobody will opt out because you’re showing NFL teams that you’re more focused on something else, other than the team goal,” Hunter said of the expanded 12-team College Football Playoff. “So I don’t think players are going to opt out of the playoffs.” Hunter and quarterback Shedeur Sanders chatted Thursday in a set of Zoom calls about turning around the program at Colorado (from 4-8 last season to bowl eligibility), chasing a Big 12 title, turning pro — Hunter acknowledged he will “for sure” — and, of course, the Heisman race, where Hunter is currently the odds-on favorite in an award each wants to see the other win. “He’s deserving of it, and if it’s between me and him, I want him to get it,” said Sanders, whose 16th-ranked Buffaloes (8-2, 6-1 Big 12, No. 16 CFP ) travel to Arrowhead Stadium to face Kansas (4-6, 3-4) this weekend. “He does a lot of amazing things that have never been done before.” Countered Hunter: “I know he wants me to win it, but I also want him to win as bad as I want to win it.” Hunter is a generational talent shining on both sides of the ball. As a receiver, he has 74 catches for 911 yards and nine touchdowns. On defense, he has picked off three passes, even though teams are reluctant to throw his direction. Like he did in high school and now in college, he believes he can do both on the next level. But he understands the trepidation of the NFL team that picks him. “They don’t want their top pick to go down too early," Hunter said. “I like when people tell me I can’t do it, because they just motivate me to continue to do what I want to do.” Sanders is turning in a stellar season as well with 27 touchdown passes, one away from tying Sefo Liufau for the most in a single season in program history. He's projected to be one of the first QBs off the draft board. The future certainly looks bright at Colorado thanks to the legacies Sanders and Hunter under coach Deion Sanders. But that's a point to ponder later. “I can’t think too much forward past Saturday,” Shedeur Sanders cracked. “The main thing is winning the Big 12 championship. That’s the main thing we’re focused on." Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Get local news delivered to your inbox!
Elway: Remorse over passing on Allen mitigated by play of NixNEW YORK , Nov. 22, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: AeroVironment, Inc. (NASDAQ: AVAV )'s merger with BlueHalo LLC. Per the terms of the proposed transaction, AeroVironment will issue approximately 18.5 million shares of AeroVironment common stock to BlueHalo. Upon closing of the proposed transaction, AeroVironment shareholders will own approximately 60.5% of the combined company. If you are an AeroVironment shareholder, click here to learn more about your legal rights and options . Innovid Corp. (NYSE: CTV )'s sale to Mediaocean for $3.15 per share. If you are an Innovid shareholder, click here to learn more about your legal rights and options . Adams Resources & Energy, Inc. (NYSE: AE )'s sale to an affiliate of Tres Energy LLC for $38.00 per share in cash. If you are an Adams shareholder, click here to learn more about your rights and options . Piedmont Lithium Inc. (NASDAQ: PLL )'s merger with Sayona Mining Limited. If you are a Piedmont shareholder, click here to learn more about your rights and options . Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] . Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP
California had a rebate for zero-emissions vehicles from 2010 to 2023Is it safe to eat turkey this Thanksgiving amid bird flu outbreak? Here’s what experts say‘Piano to Zanskar’ Conducts a Musical Journey Across the Himalayas on Documentary Showcase